CHF is a red herring most likely. Distraction.
Logic tells you that if CHF was lobbed on the table this late in these ARDS type discussions, it would be either set aside or run in parallel elsewhere so as not to derail progress.
There is no reason to wrap it all up in one contract or negotiation. It makes more sense that they are separate as the approaches to market are different.
Novartis tomorrow bout time, page-54
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
-0.030(2.08%) |
Mkt cap ! $1.627B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $1.409M | 990.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 16825 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 4055 | 6 |
View Market Depth
| Last trade - 12.39pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |